Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Iridex (IRIX) EBT (2016 - 2026)

Iridex has reported EBT over the past 17 years, most recently at $4.9 million for Q1 2026.

  • For Q1 2026, EBT fell 37.67% year-over-year to $4.9 million; the TTM value through Jan 2026 reached $670000.0, up 511.04%, while the annual FY2026 figure was $670000.0, 511.04% up from the prior year.
  • EBT for Q1 2026 was $4.9 million at Iridex, up from -$1.6 million in the prior quarter.
  • Over five years, EBT peaked at $7.8 million in Q4 2024 and troughed at -$3.4 million in Q1 2024.
  • A 5-year average of -$39176.5 and a median of -$1.7 million in 2023 define the central range for EBT.
  • Biggest five-year swings in EBT: plummeted 258.74% in 2022 and later skyrocketed 666.3% in 2023.
  • Year by year, EBT stood at -$1.2 million in 2022, then skyrocketed by 666.3% to $6.8 million in 2023, then grew by 15.74% to $7.8 million in 2024, then crashed by 120.02% to -$1.6 million in 2025, then soared by 411.41% to $4.9 million in 2026.
  • Business Quant data shows EBT for IRIX at $4.9 million in Q1 2026, -$1.6 million in Q3 2025, and -$973000.0 in Q2 2025.